Neal Ian Lindeman
Cornell University · 482 works · 43,325 citations · h-index 71
Top works
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
- Characterizing the cancer genome in lung adenocarcinoma
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
- LKB1 modulates lung cancer differentiation and metastasis
- A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK -Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations
- Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
- A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
- Response and Resistance in a Non–Small-Cell Lung Cancer Patient With an Epidermal Growth Factor Receptor Mutation and Leptomeningeal Metastases Treated With High-Dose Gefitinib
- Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy